Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemothera...

por Schmoll, Hans-Joachim, Wittig, Burghardt, Arnold, Dirk, Riera-Knorrenschild, Jorge, Nitsche, Dieter, Kroening, Hendrik, Mayer, Frank, Andel, Johannes, Ziebermayr, Reinhard, Scheithauer, Werner
Publicado 2014

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)

por Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Petzer, Andreas, Hubalek, Michael, Petru, Edgar, Sandholzer, Margit, Andel, Johannes, Balic, Marija, Melchardt, Thomas, Hauser-Kronberger, Cornelia, Schmitt, Clemens A., Ulmer, Hanno, Greil, Richard
Publicado 2021

Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: Analysis of the Austrian head and neck cancer registry of th...

por Magnes, Teresa, Wagner, Sandro M., Melchardt, Thomas, Weiss, Lukas, Rinnerthaler, Gabriel, Huemer, Florian, Kopp, Michael, Gampenrieder, Simon Peter, Mayrbäurl, Beate, Füreder, Thorsten, Lenger, Daniel, Andel, Johannes, Egle, Alexander, Greil, Richard
Publicado 2021

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study

por Piringer, Gudrun, Gruenberger, Thomas, Thaler, Josef, Kührer, Irene, Kaczirek, Klaus, Längle, Friedrich, Viragos-Toth, Istvan, Amann, Arno, Eisterer, Wolfgang, Függer, Reinhold, Andel, Johannes, Pichler, Angelika, Stift, Judith, Sölkner, Lidija, Gnant, Michael, Öfner, Dietmar
Publicado 2023

Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry

por Huemer, Florian, Weiss, Lukas, Regitnig, Peter, Winder, Thomas, Hartmann, Bernd, Thaler, Josef, Piringer, Gudrun, Schmitt, Clemens A., Eisterer, Wolfgang, Gänzer, Hannes, Wüstner, Alois, Andel, Johannes, Jagdt, Björn, Ulmer, Hanno, Greil, Richard, Wöll, Ewald
Publicado 2020

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

por Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Tinchon, Christoph, Petzer, Andreas, Balic, Marija, Heibl, Sonja, Schmitt, Clemens, Zabernigg, August Felix, Egle, Daniel, Sandholzer, Margit, Singer, Christian Fridolin, Roitner, Florian, Hager, Christopher, Andel, Johannes, Hubalek, Michael, Knauer, Michael, Greil, Richard
Publicado 2021

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia

por Steurer, Michael, Montillo, Marco, Scarfò, Lydia, Mauro, Francesca R., Andel, Johannes, Wildner, Sophie, Trentin, Livio, Janssens, Ann, Burgstaller, Sonja, Frömming, Anna, Dümmler, Thomas, Riecke, Kai, Baumann, Matthias, Beyer, Diana, Vauléon, Stéphanie, Ghia, Paolo, Foà, Robin, Caligaris-Cappio, Federico, Gobbi, Marco
Publicado 2019

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classificatio...

por Pleyer, Lisa, Burgstaller, Sonja, Stauder, Reinhard, Girschikofsky, Michael, Sill, Heinz, Schlick, Konstantin, Thaler, Josef, Halter, Britta, Machherndl-Spandl, Sigrid, Zebisch, Armin, Pichler, Angelika, Pfeilstöcker, Michael, Autzinger, Eva-Maria, Lang, Alois, Geissler, Klaus, Voskova, Daniela, Geissler, Dietmar, Sperr, Wolfgang R., Hojas, Sabine, Rogulj, Inga M., Andel, Johannes, Greil, Richard
Publicado 2016

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian m...

por Riedl, Jakob Michael, Posch, Florian, Prager, Gerald, Eisterer, Wolfgang, Oehler, Leopold, Sliwa, Thamer, Wilthoner, Klaus, Petzer, Andreas, Pichler, Petra, Hubmann, Eva, Winder, Thomas, Burgstaller, Sonja, Korger, Markus, Andel, Johannes, Greil, Richard, Neumann, Hans-Joerg, Pecherstorfer, Martin, Philipp-Abbrederis, Kathrin, Djanani, Angela, Gruenberger, Birgit, Laengle, Friedrich, Wöll, Ewald, Gerger, Armin
Publicado 2020

P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02)

por Ludwig, Heinz, Melchardt, Thomas, Sormann, Siegfried, Schreder, Martin, Andel, Johannes, Hartmann, Bernd, Tinchon, Christoph, Zojer, Niklas, Gunsilius, Eberhard, Podar, Klaus, Egle, Alexander, Willenbacher, Wolfgang, Woell, Ewald, Ruckser, Reinhard, Bozic, Boris, Theresa Krauth, Maria, Petzer, Andreas, Schmitt, Clemens A., Machherndl-Spandl, Sigrid, Agis, Hermine, Fillitz, Michael, Wang, Song-Yau, Knop, Stefan, Paiva, Bruno, Greil, Richard
Publicado 2023

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Aust...

por Pleyer, Lisa, Döhner, Hartmut, Dombret, Hervé, Seymour, John F., Schuh, Andre C., Beach, CL, Swern, Arlene S., Burgstaller, Sonja, Stauder, Reinhard, Girschikofsky, Michael, Sill, Heinz, Schlick, Konstantin, Thaler, Josef, Halter, Britta, Machherndl Spandl, Sigrid, Zebisch, Armin, Pichler, Angelika, Pfeilstöcker, Michael, Autzinger, Eva M., Lang, Alois, Geissler, Klaus, Voskova, Daniela, Sperr, Wolfgang R., Hojas, Sabine, Rogulj, Inga M., Andel, Johannes, Greil, Richard
Publicado 2017

The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

por Bendell, Johanna C., Sauri, Tamara, Gracián, Antonio Cubillo, Alvarez, Rafael, López‐López, Carlos, García‐Alfonso, Pilar, Hussein, Maen, Miron, Maria‐Luisa Limon, Cervantes, Andrés, Montagut, Clara, Vivas, Cristina Santos, Bessudo, Alberto, Plezia, Patricia, Moons, Veerle, Andel, Johannes, Bennouna, Jaafar, van der Westhuizen, Andre, Samuel, Leslie, Rossomanno, Simona, Boetsch, Christophe, Lahr, Angelika, Franjkovic, Izolda, Heil, Florian, Lechner, Katharina, Krieter, Oliver, Hurwitz, Herbert
Publicado 2019

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial

por Egle, Alexander, Melchardt, Thomas, Obrtlíková, Petra, Smolej, Lukáš, Kozák, Tomáš, Steurer, Michael, Andel, Johannes, Burgstaller, Sonja, Mikušková, Eva, Gercheva, Liana, Nösslinger, Thomas, Papajík, Tomáš, Ladická, Miriam, Girschikofsky, Michael, Hrubiško, Mikuláš, Jäger, Ulrich, Voskova, Daniela, Pecherstorfer, Martin, Králiková, Eva, Burcoveanu, Christina, Spasov, Emil, Petzer, Andreas, Mihaylov, Georgi, Raynov, Julian, Oexle, Horst, Zabernigg, August, Flochová, Emília, Palášthy, Stanislav, Stehlíková, Olga, Doubek, Michael, Altenhofer, Petra, Weiss, Lukas, Magnes, Teresa, Pleyer, Lisa, Klingler, Anton, Mayer, Jiří, Greil, Richard
Publicado 2019